Exin Therapeutics, Inc.

Exin Therapeutics is an AI-driven gene therapy company targeting circuit dysfunction. The platform combines multimodal in vivo neural data collected in house (electrophysiology, behavior & transcriptomics) with deep learning to pinpoint circuit-level drivers of disease, then corrects them using targeted gene therapies that rebalance the physiological patterns of neural activity. Exin’s platform scales to multiple CNS indications where circuit dysfunction is the root cause, with current programs in epilepsy, Parkinson’s disease and profound autism.